Applied Aerospace & Defense (AADX) Q2 2026 Earnings Call Transcript

Applied Aerospace & Defense reported Q2 revenue of $167.3M (+47.4% YoY) and record adjusted EBITDA of $36.4M (+38.5% YoY), alongside a record contract backlog of $1.13B (from $871M). The company’s IPO generated $635.7M net proceeds used to reduce debt by $626.2M, bringing pro forma net leverage down to 2.7x. Full-year 2026 guidance raised/maintained at $670M–$690M revenue and $150M–$155M adjusted EBITDA, with gross margin at 22.2% impacted by ~6% from IPO-related share-based compensation and margin pressure expected to ease as new programs move past learning curves.

Analysis

This is a capacity-leverage story more than a headline growth story. The important mechanism is that near-term revenue is being pulled through a platform with meaningful spare floor space, so incremental dollars should convert better once the newer programs clear their learning curves. That makes the next 2-3 quarters less about top-line surprise and more about whether margin normalization and working-capital release confirm the operating model.

Relative winners are the launch, missile-defense, and next-gen aviation programs that need a qualified dual-source or sole-source manufacturing partner; the company is becoming a bottleneck solver for primes rather than a commodity vendor. The secondary benefit may accrue to smaller, fragmented suppliers that can be acquired or partnered into this platform, while pure point-solution shops risk being squeezed as customers prefer integrated content and faster qualification. Near-term cost pressure from aluminum and supply-chain congestion looks manageable unless it broadens into labor or electronics, where the pass-through story becomes harder.

The contrarian risk is that investors may underwrite the IPO as a clean quality compounder while ignoring how much of the reported earnings power is still adjusted, acquisition-driven, or dependent on a few cadence-sensitive programs. The most important falsifiers are a slip in launch or next-gen defense ramp, backlog conversion that stalls into 2027, or no cash release from the first-half working-capital build. If any of those happen, the multiple should compress quickly because the market will stop paying for visibility that is not turning into free cash flow.

Key Decisions for Investors

• Long AADX on pullbacks over the next 1-2 weeks; target a 3-6 month re-rate as 2H margins improve and working capital converts to cash. Risk/reward is attractive if the stock can hold above the IPO-issue area after the first post-IPO digested print.
• Pair trade: long AADX / short ITA or XAR for the next 1-2 quarters to isolate idiosyncratic backlog and margin inflection against broader aerospace-defense beta. Falsify the trade if AADX misses 2H EBITDA margin expansion or guides backlog conversion lower.
• If options are liquid, buy AADX 6-12 month call spreads instead of outright equity to express the 2027 visibility story while limiting downside from program timing risk. Best entry is after any post-earnings volatility reset.
• Set an alert for any disclosure that SpaceX/Blue Origin cadence or a major defense ramp slips into 2027; that is the cleanest catalyst to de-rate the name. If that occurs, reduce/exit longs because the thesis shifts from visibility to delay.